Pharmacological upregulation of prostate-specific membrane antigen (PSMA) expression in prostate cancer cells-Reference-Cited by-同舟云学术

Pharmacological upregulation of prostate-specific membrane antigen (PSMA) expression in prostate cancer cells

Published:2018-04-06 Issue:10 Volume:78 Page:758-765
ISSN:0270-4137
Container-title:The Prostate
language:en
Short-container-title:Prostate

Author:

Kranzbühler Benedikt¹^ORCID,Salemi Souzan¹,Umbricht Christoph A.²,Müller Cristina²,Burger Irene A.³,Sulser Tullio¹,Eberli Daniel¹

Affiliation:

1. Department of Urology, Laboratory for Tissue Engineering and Stem Cell Therapy; University Hospital Zürich; Zürich Switzerland

2. Center for Radiopharmaceutical Sciences ETH-PSI-USZ; Paul Scherrer Institut; Villigen-PSI Switzerland

3. Department of Nuclear Medicine; University Hospital of Zürich; Zürich Switzerland

Publisher

Wiley

Subject

Urology,Oncology

Reference36 articles.

1. Molecular cloning of a complementary DNA encoding a prostate-specific membrane antigen;Israeli;Cancer Res,1993

2. Expression of prostate specific membrane antigen (PSMA) in prostatic adenocarcinoma and prostatic intraepithelial neoplasia;Marchal;Histol Histopathol,2004

3. Prostate specific membrane antigen expression in prostatic intraepithelial neoplasia and adenocarcinoma: a study of 184 cases;Bostwick;Cancer,1998

4. PSMA expression is highly homogenous in primary prostate cancer;Tsourlakis;Appl Immunohistochem Mol Morphol,2015

5. Sensitivity, specificity, and predictors of positive 68Ga-prostate-specific membrane antigen positron emission tomography in advanced prostate cancer: a systematic review and meta-analysis;Perera;Eur Urol,2016

Cited by 49 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Prostate-Specific Membrane Antigen–Targeted Therapies for Prostate Cancer: Towards Improving Therapeutic Outcomes;European Urology;2023-12

2. Towards Improving the Efficacy of PSMA-Targeting Radionuclide Therapy for Late-Stage Prostate Cancer—Combination Strategies;Current Oncology Reports;2023-10-20

3. Radiolabeled iron oxide nanoparticles functionalized with PSMA/BN ligands for dual-targeting of prostate cancer;Frontiers in Nuclear Medicine;2023-09-20

4. Improved Prostate-Specific Membrane Antigen (PSMA) Stimulation Using a Super Additive Effect of Dutasteride and Lovastatin In Vitro;International Journal of Molecular Sciences;2023-08-02

5. Bipolar Androgen Therapy: When Excess Fuel Extinguishes the Fire;Biomedicines;2023-07-24